Sherryl Baker

2.0k total citations
26 papers, 1.5k citations indexed

About

Sherryl Baker is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Microbiology. According to data from OpenAlex, Sherryl Baker has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Microbiology. Recurrent topics in Sherryl Baker's work include Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Sherryl Baker is often cited by papers focused on Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Sherryl Baker collaborates with scholars based in United States, South Africa and United Kingdom. Sherryl Baker's co-authors include Daniel A. Scott, William C. Gruber, Shabir A. Madhi, George R. Siber, Wendy G. Mitchell, Peter R. Paradiso, Keith P. Klugman, Ih Chang, Philip Fernsten and Mathuram Santosham and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and Biometrics.

In The Last Decade

Sherryl Baker

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherryl Baker United States 17 1.0k 367 237 136 114 26 1.5k
Martijn Weisfelt Netherlands 19 1.6k 1.5× 1.8k 5.0× 453 1.9× 336 2.5× 155 1.4× 28 2.3k
Sabina Schmitt‐Grohé Germany 16 625 0.6× 535 1.5× 90 0.4× 176 1.3× 28 0.2× 35 1.3k
Seilesh Kadambari United Kingdom 20 651 0.6× 113 0.3× 156 0.7× 399 2.9× 21 0.2× 54 1.0k
Andrew Winter United Kingdom 18 284 0.3× 357 1.0× 101 0.4× 222 1.6× 41 0.4× 63 1.1k
James Todd United States 15 393 0.4× 183 0.5× 316 1.3× 357 2.6× 13 0.1× 39 910
Stephen C. Aronoff United States 26 494 0.5× 97 0.3× 218 0.9× 168 1.2× 39 0.3× 88 1.7k
Alex Lund Laursen Denmark 28 1.0k 1.0× 115 0.3× 96 0.4× 1.1k 8.1× 126 1.1× 125 2.5k
David H. Carver United States 16 364 0.3× 62 0.2× 108 0.5× 202 1.5× 127 1.1× 44 1.1k
Hanspeter E. Gnehm Switzerland 18 227 0.2× 141 0.4× 232 1.0× 96 0.7× 19 0.2× 36 1.2k
Noni MacDonald Canada 12 281 0.3× 150 0.4× 94 0.4× 99 0.7× 47 0.4× 22 569

Countries citing papers authored by Sherryl Baker

Since Specialization
Citations

This map shows the geographic impact of Sherryl Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherryl Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherryl Baker more than expected).

Fields of papers citing papers by Sherryl Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherryl Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherryl Baker. The network helps show where Sherryl Baker may publish in the future.

Co-authorship network of co-authors of Sherryl Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Sherryl Baker. A scholar is included among the top collaborators of Sherryl Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherryl Baker. Sherryl Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Madhi, Shabir A., Luis M. Rivera, Xavier Sáez‐Llorens, et al.. (2018). Factors influencing access of pregnant women and their infants to their local healthcare system: a prospective, multi-centre, observational study. BMC Pregnancy and Childbirth. 18(1). 29–29. 5 indexed citations
4.
Donders, Gilbert, Scott A. Halperin, Roland Devlieger, et al.. (2016). Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine. Obstetrics and Gynecology. 127(2). 213–221. 70 indexed citations
5.
Madhi, Shabir A., Clare Cutland, Lisa Jose, et al.. (2016). Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. The Lancet Infectious Diseases. 16(8). 923–934. 119 indexed citations
6.
Gadzinowski, Janusz, S. Tansey, Jacek Wysocki, et al.. (2014). Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 Given to Healthy Infants at 2, 3, 4 and 12 Months of Age. The Pediatric Infectious Disease Journal. 34(2). 180–185. 6 indexed citations
7.
Snape, Matthew D., Tessa M. John, Eva Galiza, et al.. (2010). Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age. The Pediatric Infectious Disease Journal. 29(12). e80–e90. 102 indexed citations
8.
Bryant, Kristina A., et al.. (2010). Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine. PEDIATRICS. 125(5). 866–875. 137 indexed citations
9.
10.
11.
Scott, Daniel A., et al.. (2008). Phase 1 trial of 13‐valent pneumococcal conjugate vaccine in Japanese adults. Pediatrics International. 50(3). 295–299. 31 indexed citations
12.
Scott, Daniel A., Steven F. Komjathy, Branda Hu, et al.. (2007). Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 25(33). 6164–6166. 83 indexed citations
13.
Siber, George R., Ih Chang, Sherryl Baker, et al.. (2007). Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine. 25(19). 3816–3826. 278 indexed citations
14.
15.
Reid, Malcolm S., Paul Casadonte, Sherryl Baker, et al.. (2005). A placebo‐controlled screening trial of olanzapine, valproate, and coenzyme Q10/L‐carnitine for the treatment of cocaine dependence. Addiction. 100(s1). 43–57. 38 indexed citations
16.
Reid, Malcolm S., Burt Angrist, Sherryl Baker, et al.. (2005). A placebo‐controlled screening trial of celecoxib for the treatment of cocaine dependence. Addiction. 100(s1). 32–42. 12 indexed citations
17.
Mitchell, Wendy G., Lawrence M. Scheier, & Sherryl Baker. (1994). Psychosocial, Behavioral, and Medical Outcomes in Children with Epilepsy: A Developmental Risk Factor Model Using Longitudinal Data. PEDIATRICS. 94(4). 471–477. 73 indexed citations
18.
Baker, Sherryl. (1990). Examination of designs for phase I clinical trials. Controlled Clinical Trials. 11(4). 257–257. 1 indexed citations
19.
Diament, Michael J., et al.. (1987). Prevalence of Incidental Paranasal Sinuses Opacification in Pediatric Patients. Journal of Computer Assisted Tomography. 11(3). 426–431. 126 indexed citations
20.
Gonen, Boas, et al.. (1987). Immunogenicity of malondialdehyde-modified low density lipoproteins. Atherosclerosis. 65(3). 265–272. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martijn Weisfelt Breakdown of academic impact, for papers by Sabina Schmitt‐Grohé Breakdown of academic impact, for papers by Seilesh Kadambari Breakdown of academic impact, for papers by Andrew Winter Breakdown of academic impact, for papers by James Todd Breakdown of academic impact, for papers by Stephen C. Aronoff Breakdown of academic impact, for papers by Alex Lund Laursen Breakdown of academic impact, for papers by David H. Carver Breakdown of academic impact, for papers by Hanspeter E. Gnehm Breakdown of academic impact, for papers by Noni MacDonald
Rankless by CCL
2026